Update on the use of etanercept across a spectrum of rheumatoid disorders. - Wikidata - awgldk - TriplyDB

Update on the use of etanercept across a spectrum of rheumatoid disorders.

Update on the use of etanercept across a spectrum of rheumatoid disorders.

http://www.wikidata.org/entity/Q37290628

about

Soluble T cell receptor Vβ domains engineered for high-affinity binding to staphylococcal or streptococcal superantigens

P2860

Q37617797-2B01B5CB-7AA8-4921-A57F-8FE30C55E660

P2860

Update on the use of etanercept across a spectrum of rheumatoid disorders.

http://www.wikidata.org/entity/Q37290628

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Update on the use of etanercept across a spectrum of rheumatoid disorders.

@en

Update on the use of etanercept across a spectrum of rheumatoid disorders.

@nl

type

label

Update on the use of etanercept across a spectrum of rheumatoid disorders.

@en

Update on the use of etanercept across a spectrum of rheumatoid disorders.

@nl

prefLabel

Update on the use of etanercept across a spectrum of rheumatoid disorders.

@en

Update on the use of etanercept across a spectrum of rheumatoid disorders.

@nl

P1433

Q37290628-A7A9E78A-589B-4F94-82CA-FDC607CA454D

P1476

Q37290628-1E8B1B5E-6585-4017-ACF7-28EA86F6EF53

P2093

Q37290628-E51B2893-4EE9-4257-A3E1-3CC1E221B705

P2860

Q37290628-01A4C44A-13F1-4A87-A4E7-EDD022C42A66

Q37290628-057ADB72-532B-4710-B66A-98B22F408779

Q37290628-057FA9F8-72CB-4F42-96EA-4DAD6F7FB353

Q37290628-19076E06-B46E-4366-9868-A54291DA5745

Q37290628-2A632E80-99E0-4F38-89AA-AD774127D564

Q37290628-32431755-8ED5-43E8-BD68-F8C2E33037C2

Q37290628-3A9417CB-F5A3-4833-AE51-0220D7AE744E

Q37290628-3F2C1803-C469-40A8-93E5-DA57BE22DE8F

Q37290628-422EC17C-7B72-45D5-A559-8261AE0B1FB6

Q37290628-43DC5F5A-0721-45FF-91D0-654CD8FA509E

P304

Q37290628-D09801B5-0250-4C8C-A8A8-31EDEFF34698

P31

Q37290628-F2B572CF-E93C-4DE6-91BF-312108B56605

P356

Q37290628-FFE5DE8A-CA3F-482A-97DF-02008CB55665

P433

Q37290628-473DB108-8383-4051-A8E9-03B7D0BF408D

P478

Q37290628-642272ED-3EB1-402E-B30C-6C32DCEF469B

P577

Q37290628-FBCFBA06-E4D2-43B9-B5FA-BEFCBA303EB6

P698

Q37290628-1AECD741-3DBC-498A-BC1A-787B3A3D8915

P932

Q37290628-509146D0-9560-4F99-886D-378941834BA5

P356

P1433

Biologics: Targets and Therapy

P1476

Update on the use of etanercept across a spectrum of rheumatoid disorders.

@en

P2093

Bernard Combe

http://www.w3.org/2001/XMLSchema#string

P2860

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept: clinical and magnetic resonance imaging data.

Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.

Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial.

Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.

Cytokine pathways and joint inflammation in rheumatoid arthritis.

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis.

Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate.

Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

P304

165-173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/BTT.S1379

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19707351

http://www.w3.org/2001/XMLSchema#string

P932

2721350

http://www.w3.org/2001/XMLSchema#string